Abstract
Introduction:
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer-related mortality worldwide. While the Triggering Receptor Expressed on Myeloid Cells 1 (TREM1) is well-known for its role in amplifying inflammation within the tumor microenvironment (TME), its tumor-intrinsic role remains poorly defined. Liver cancer stem-like cells (LCSLCs), charecerized by expression of CD133 and EpCAM, are critical for HCC initiation, metastasis, recurrence, and therapy resistance.
Methods:
We used flow cytometry to assess TREM1 expression in LCSLCs and employed CRISPR-Cas9 gene editing to knock out TREM1 in HCC cell lines. Functional assays, including proliferation, migration, apoptosis, clonogenicity, and spheroid formation, were performed. Cell line-derived xenograft (CDX) models were used to evaluate in vivo tumorigenicity. Transcriptomic profiling was conducted to explore downstream effects of TREM1 deletion. Additionally, a pharmacological inhibitor of TREM1 (VJDT) was used to validate the therapeutic potential of targeting TREM1 in vivo.
Results:
TREM1 was highly expressed in CD133+EpCAM+ LCSLCs. Knockout of TREM1 significantly impaired proliferation and migration while promoting apoptosis in HCC cells. In LCSLCs, TREM1 silencing reduced clonogenic ability and spheroid formation, indicating loss of self-renewal and stemness. In CDX models, TREM1-deficient LCSLCs exhibited markedly reduced tumorigenicity. Transcriptomic analysis revealed distinct, context-dependent gene expression changes in nuclear and extracellular signaling pathways following TREM1 loss. Pharmacologic inhibition of TREM1 with VJDT recapitulated the tumor-suppressive effects observed in genetic models.
Discussion:
Our findings establish TREM1 as a critical tumor-intrinsic regulator of LCSLC survival and tumorigenic potential, independent of its known immunomodulatory role in the TME. Targeting TREM1 may therefore represent a promising dual-action therapeutic strategy to disrupt both cancer stem-like cell function and the pro-inflammatory tumor milieu in HCC.